ESTUTC-5 New YorkLog in Sign up

NRXP
NRX Pharmaceuticals, Inc. Common Stock
stockNASDAQ

At CloseNov 6, 2026 3:59:57 PM EST

2.37USD+4.405%(+0.10)604,422

Pre-marketNov 6, 2026 9:28:30 AM EST

2.32USD+2.203%(+0.05)

After-hoursNov 6, 2026 4:54:30 PM EST

2.39USD+0.844%(+0.02)

NRXP News

Day breaks

05:30 AM ESTNRXP Maintains Buy Rating by Ascendiant Capital -- Price Target Raised to $51 ·

GuruFocus

11:18 AM EDTNRx Pharmaceuticals, Inc. (NRXP) Discusses FDA Approval of Preservative-Free Ketamine Transcript ·

Seeking Alpha

08:17 AM EDTWhy is NRX Pharmaceuticals stock surging today? ·

Investing.com

07:39 AM EDTNRx Pharma rises on FDA nod for generic ketamine injection ·

Seeking Alpha

07:04 AM EDTNRx Pharmaceuticals receives FDA approval for ketamine drug ·

Investing.com

07:00 AM EDTNRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date ·

GlobeNewswire Inc.

04:00 PM EDTNRx Pharmaceuticals (Nasdaq: NRXP) to Host Conference Call on October 30, 2026 to Discuss Regulatory Milestone for Preservative-Free Ketamine ·

GlobeNewswire Inc.

08:30 AM EDTNRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine ·

GlobeNewswire Inc.

08:27 AM EDTNRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine ·

GlobeNewswire Inc.

07:21 AM EDTNRx Defense Systems awarded $11M DARPA prime contract ·

Seeking Alpha

07:00 AM EDTNRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression ·

GlobeNewswire Inc.

03:11 PM EDTNRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine ·

GlobeNewswire Inc.